Frontiers in medicine

Molecular diversity

Journal of clinical nursing

Journal of global antimicrobial resistance

molecular pharmaceutics

Frontiers in bioengineering and biotechnology

mycopathologia

Viruses

case reports in infectious diseases

letters in applied microbiology

BMC genomics

the international journal of tuberculosis and lung disease : the official journal of the international union against tuberculosis and lung disease

Journal of translational medicine

genome medicine

global health, science and practice

antiviral chemistry & chemotherapy

reviews on environmental health

bmj open gastroenterology

expert review of medical devices

international journal for parasitology drugs and drug resistance

research (washington, dc)

parasite immunology

journal of chemotherapy (florence, italy)

Protein science : a publication of the Protein Society

international journal of clinical and experimental pathology

[1] Population genomic and evolutionary modelling analyses reveal a single major QTL for ivermectin drug resistance in the pathogenic nematode, Haemonchus contortus.

[2] Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.

[3] Carbon nanomaterials: a new way against tuberculosis.

[4] Chemically Binding Scaffolded Anodes with 3D Graphene Architectures Realizing Fast and Stable Lithium Storage.

[5] Structural Insights into Phosphopantetheinyl Hydrolase PptH from Mycobacterium tuberculosis.

[6] Early Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone.

[7] Environmental pharmacology: source, impact and solution.

[8] Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

[9] Social Media and Drug Resistance in Nursing Training: Using a Twitterchat to develop an international community of practice for antimicrobial resistance.

[10] New approach to identify Colistin-resistant Pseudomonas aeruginosa by High-Resolution Melting Curve (HRM) Analysis assay.

[11] The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.

[12] Autophagy-related genes affect drug resistance of mycobacteria by regulating autophagy.

[13] Evaluation of MTBDR for detecting resistance in to second-line drugs.

[14] Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies.

[15] Potential strategies for the management of drug resistant tuberculosis.

[16] Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.

[17] HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.

[18] A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.

[19] Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Associated With Pyrazinamide Resistance.

[20] Effects of a Peer-Led Intervention on HIV Care Continuum Outcomes Among Contacts of Children, Adolescents, and Young Adults Living With HIV in Zimbabwe.

[21] Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study

[22] phenotypic and transcriptional profiling in entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance

[23] bacterial profile and antimicrobial susceptibility pattern in catheter related nosocomial infections.

[24] resistance of schistosomes to hycanthone and oxamniquine

[25] prediction of cancer drug resistance and implications for personalized medicine.

[26] incidence and antibiotic susceptibility pattern of most common bacterial pathogen causing urinary tract infection (uti) in tehran, iran, 2012-2013

[27] patient automedication and professional prescription pattern in an urgency service in brazil

[28] doença pulmonar por mycobacterium tuberculosis e micobactérias não-tuberculosas entre pacientes recém-diagnosticados como hiv positivos em moçambique, África mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent hiv infection in mozambique

[29] breast cancer-initiating cells: insights into novel treatment strategies

[30] chimerization at the aqp2–aqp3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical trypanosoma brucei gambiense isolates

[31] drug susceptibility of plasmodium falciparum in the western amazon region, state of acre, brazil susceptibilidade a droga, do plasmodium falciparum, na amazônia ocidental, estado do acre, brasil

[32] antimicrobial susceptibility pattern of pseudomonas aeruginosa isolated from patients referring to hospitals

[33] the mechanism of ligand-independent activation of estrogen receptor in letrozole-resistant breast cancer cells

[34] the presence of aac (6 ') ie / aph (2 "), aph (3') - iiia1, ant (4 ') - ia1 genes and determining methicillin resistance in staphylococcus epidermidis and staphylococcus saprophyticus strains isolated from clinical specimens

[35] advanced cell culture techniques for cancer drug discovery

[36] mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the amazon region of brazil

[37] current status of poly(adp-ribose) polymerase inhibitors and future directions

[38] oxidative phosphorylation activation is an important characteristic of dox resistance in hepatocellular carcinoma cells

[39] política de antibióticos

[40] a preliminary study on the screening of emerging drug resistance among the caries pathogens isolated from carious dentine

[41] importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance

[42] exploring small extracellular vesicles for precision medicine in prostate cancer

[43] avances recientes en métodos moleculares para el diagnóstico precoz y tuberculosis resistente al tratamiento

[44] proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer

[45] caracterización de aislamientos invasivos de s. pneumoniae, h. influenzae y n. meningitidis en américa latina y el caribe: sireva ii, 2000-2005 characterization of invasive isolates of s. pneumoniae, h. influenzae, and n. meningitidis in latin america and the caribbean: sireva ii, 2000-2005

[46] drug resistance analysis by next generation sequencing in leishmania

[47] distribución de genes codificadores de β-lactamasas de espectro extendido en aislamientos de klebsiella pneumoniae de hospitales de bogotá, d.c., colombia

[48] nanoparticles for control of biofilms of acinetobacter species

[49] in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.

[50] genetic variation and drug resistance mutation of influenza virus during 2013-2014 in beijing, china: a report of 37 cases

[51] the hsp90 co-chaperones sti1, aha1, and p23 regulate adaptive responses to antifungal azoles

[52] inter and intratumour heterogeneity: a barrier to individualised medical therapy in renal cell carcinoma?

[53] schistosome abc multidrug transporters: from pharmacology to physiology

[54] prevalence of r-type acssut in strains of salmonella serovar typhimurium dt193 isolated from human infections in brazil prevalencia de resistencia de tipo acssut en cepas de salmonella serovariedad typhimurium dt193 aisladas a partir de infecciones humanas en el brasil

[55] the molecular chaperone grp78/bip in the development of chemoresistance: mechanism and possible treatment

[56] stat3-mediated metabolic reprogramming in cellular transformation and implications for drug resistance

[57] vigilancia del consumo de antimicrobianos en hospitales de méxico: situación actual y guía práctica para su implementación surveillance of antimicrobial drug use in mexican hospitals: current situation and practical guidelines for its implementation

[58] cell volume regulation in epithelial physiology and cancer

[59] structural aspects of drug resistance and inhibition of hiv-1 reverse transcriptase

[60] synergistic effect of haloduracin and chloramphenicol against clinically important gram-positive bacteria

[61] susceptibilidad antimicrobiana y bases genéticas de la resistencia de cepas de enterococcus causantes de infecciones en cuba antimicrobial susceptibility and genetic bases for resistance of infection-causing enterococcus strains in cuba

[62] role of integrin alpha4 in drug resistance of leukemia

[63] clinical features of mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentations

[64] efficacy of 3 anthelmintics in communally grazed sheep as reflected by faecal egg count reduction tests in a semi-arid area of south africa : short communication

[65] unique flap conformation in an hiv-1 protease with high-level darunavir resistance

[66] occurrence and antimicrobial resistance of salmonella spp. and escherichia coli isolates in apparently healthy slaughtered cattle, sheep and goats in east azarbaijan province

[67] bacteriological study of neonatal septicaemia cases and their in vitro sensitivity to antimicrobial agents.

[68] targeting intracellular calcium signaling ([ca2+]i) to overcome acquired multidrug resistance of cancer cells: a mini-overview

[69] Abstracts from the 2012 BNOS Conference

[70] The opposing roles of Wnt-5a in cancer - British Journal of Cancer

[71] Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.

[72] Pyocyanin, a Metabolite of Pseudomonas Aeruginosa, Exhibits Antifungal Drug Activity Through Inhibition of a Pleiotropic Drug Resistance Subfamily FgABC3.

[73] Emerging roles of exosomal miRNAs in breast cancer drug resistance.

[74] Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China

[75] Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

[76] Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam

[77] Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt

[78] Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China

[79] A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

[80] Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China

[81] Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

[82] HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan

[83] Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case

[84] Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001–2010 in Kolkata, India: role of integrons, plasmids, and topoisomerase mutations

[85] Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]

[86] Potential and use of bacterial small RNAs to combat drug resistance: a systematic review

[87] Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt

[88] High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

[89] Current perspective on emergence, diagnosis and drug resistance in Candida auris

[90] Drug resistance in influenza A virus: the epidemiology and management

[91] Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial

[92] Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

[93] Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China

[94] Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

[95] Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China

[96] Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

[97] Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India

[98] Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam

[99] Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt

[100] Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China

[101] A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections